Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | ELTXElicio Therapeutics, Inc.FY2022 · Dec |
|---|---|
| Revenue | $2.30M |
| Revenue, yoy | −91.9% |
| Net income | $39.57M |
| Net income, yoy | +23.8% |
| Net margin | — |
| Free cash flow | $36.97M |
| FCF margin | — |
| EPS, diluted | $2.58 |
Add another company.